2021
Transfusion Preparedness in the Labor and Delivery Unit
Benson A, Metcalf R, Cail K, Rollins M, Warrick C, Falkner D, Clark E, Nelson R, Einerson B. Transfusion Preparedness in the Labor and Delivery Unit. Obstetrics And Gynecology 2021, 138: 788-794. PMID: 34619726, DOI: 10.1097/aog.0000000000004571.Peer-Reviewed Original ResearchConceptsDelivery unitYears postimplementationSingle-center implementation studyDeliveries per yearLabor and Delivery UnitEvaluate patient safetyHealth system perspectivePreimplementation yearIntensive care unit admissionPatient safetyRed blood cellsMaternal morbidityImplementation studyPostimplementationScreening policyPreimplementationTransfusion-related costsPositive antibody screenHigh-risk patientsPatient outcomesUnit admissionCost dataResource utilization metricsStudy periodUtilization metrics
2020
Passive anti‐C acquired in the setting of Rh immune globulin administration following Rh mismatched apheresis platelet transfusion: A case series
Sostin N, Ross R, Balbuena‐Merle R, Hendrickson JE, Tormey CA. Passive anti‐C acquired in the setting of Rh immune globulin administration following Rh mismatched apheresis platelet transfusion: A case series. Journal Of Clinical Apheresis 2020, 35: 224-226. PMID: 32110829, DOI: 10.1002/jca.21773.Peer-Reviewed Original ResearchConceptsPlatelet transfusionsRh immune globulin administrationRisk/benefit ratioApheresis platelet transfusionImmune globulin administrationRhIG immunoprophylaxisImmune globulinTransfusion supportAlloantibody formationCase seriesNegative recipientsAlloimmunization riskRhIG administrationReproductive agePassive transferPLT transfusionsTransfusionBlood bankBenefit ratioRhIGApheresis PLTsAdministrationImmunoprophylaxisPatientsSetting
2019
Chapter Six The chemical and laboratory investigation of hemolysis
Siddon AJ, Tormey CA. Chapter Six The chemical and laboratory investigation of hemolysis. Advances In Clinical Chemistry 2019, 89: 215-258. PMID: 30797470, DOI: 10.1016/bs.acc.2018.12.006.Peer-Reviewed Original ResearchConceptsRed blood cellsSignificant clinical issueDivision of HematologyLaboratory investigationsPathophysiology of hemolysisPrimary disorderDisease processHemolytic disordersClinical issuesPathologic formsClinical pathologyBlood cellsTransfusion medicineClinical interpretationHemolysisClinical laboratoriesClinical chemistryLaboratory basisDisordersAssaysAbnormal breakdownPathophysiologyPathologyHematology
2017
How do we perform and bill for blood bank physician consultative services?
Jhang JS, Francis RO, Winkler A, Tormey C. How do we perform and bill for blood bank physician consultative services? Transfusion 2017, 57: 2311-2318. PMID: 28833250, DOI: 10.1111/trf.14264.Peer-Reviewed Original ResearchMeSH KeywordsBlood BanksFees and ChargesHumansPhysiciansReferral and ConsultationUnited StatesWorkforceConceptsIndividual patientsTertiary care teaching hospitalCurrent Procedural Terminology codesPhysician servicesTransfusion medicine physiciansProcedural Terminology codesHealth care providersComponent therapyProvider educationTransfusion reactionsBlood productsTeaching hospitalClinical significanceInappropriate testingCare providersMedicine physiciansTerminology codesApheresis proceduresPatientsPhysiciansConsultative servicesLaboratory test resultsHealth careMedical servicesMedical direction
2016
Results of a Nationwide Capacity Survey of Hospitals Providing Trauma Care in War-Affected Syria
Mowafi H, Hariri M, Alnahhas H, Ludwig E, Allodami T, Mahameed B, Koly JK, Aldbis A, Saqqur M, Zhang B, Al-Kassem A. Results of a Nationwide Capacity Survey of Hospitals Providing Trauma Care in War-Affected Syria. JAMA Surgery 2016, 151: 815-22. PMID: 27332144, DOI: 10.1001/jamasurg.2016.1297.Peer-Reviewed Original ResearchMeSH KeywordsBlood BanksBlood TransfusionEquipment and Supplies, HospitalHealth Services AccessibilityHospitalsHumansMaintenance and Engineering, HospitalNursesPharmacy Service, HospitalRehabilitationRenal Replacement TherapySurgeonsSurgical Procedures, OperativeSurveys and QuestionnairesSyriaTrauma CentersWarfareWorkforceConceptsTrauma hospitalTrauma careHealth infrastructureRenal replacement therapyEssential surgical servicesEmergency surgeryTomographic scannerReplacement therapyOxygen cylindersInpatient wardsBlood productsSurgical hospitalsSurgical servicesPharmacy servicesPediatric ventilatorsUnmet needHospitalRehabilitative servicesWidespread injuryPatientsWhole bloodPortable X-ray machineCapacity SurveyNationwide surveySurgeryRed Blood Cell Antibodies in Hematology/Oncology Patients Interpretation of Immunohematologic Tests and Clinical Significance of Detected Antibodies
Hendrickson JE, Tormey CA. Red Blood Cell Antibodies in Hematology/Oncology Patients Interpretation of Immunohematologic Tests and Clinical Significance of Detected Antibodies. Hematology/Oncology Clinics Of North America 2016, 30: 635-651. PMID: 27113001, DOI: 10.1016/j.hoc.2016.01.006.Peer-Reviewed Original ResearchConceptsRed blood cell transfusionRed blood cell antibodiesRBC alloimmunization rateBlood cell transfusionManagement of patientsDevelopment of alloantibodiesBlood group antigensAlloimmunization rateRBC alloimmunizationSuch alloantibodiesCell transfusionCell antibodiesClinical significanceHemolytic anemiaPatients' interpretationsDetected antibodiesTransfusionGroup antigensBlood bankCompatible unitsAntibodiesAlloantibodiesOncology disordersDeleterious consequencesAlloimmunization
2015
Variation in vital signs resulting from blood component administration in adults
Gehrie EA, Hendrickson JE, Tormey CA. Variation in vital signs resulting from blood component administration in adults. Transfusion 2015, 55: 1866-1871. PMID: 25867097, DOI: 10.1111/trf.13060.Peer-Reviewed Original Research
2014
Use of a Cytokine-Release Assay to Demonstrate Loss of Platelet Secretory Capacity During Blood Bank Processing and Storage
Tormey CA, Stack G. Use of a Cytokine-Release Assay to Demonstrate Loss of Platelet Secretory Capacity During Blood Bank Processing and Storage. Archives Of Pathology & Laboratory Medicine 2014, 138: 1481-7. PMID: 25357109, DOI: 10.5858/arpa.2013-0680-oa.Peer-Reviewed Original ResearchThe Development and Implementation of, and First Years' Experience With, a Massive/Emergency Transfusion Protocol (Damage Control Hematology Protocol) in a Veterans Affairs Hospital
Gehrie EA, Tormey CA. The Development and Implementation of, and First Years' Experience With, a Massive/Emergency Transfusion Protocol (Damage Control Hematology Protocol) in a Veterans Affairs Hospital. Military Medicine 2014, 179: 1099-1105. PMID: 25269127, DOI: 10.7205/milmed-d-14-00045.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overBlood BanksBlood Grouping and CrossmatchingBlood Loss, SurgicalBlood TransfusionClinical AuditClinical ProtocolsConnecticutEmergenciesErythrocyte TransfusionFactor VIIaFactor VIIIFibrinogenHematemesisHospitals, VeteransHumansLaboratories, HospitalMalePlasma ExchangePlatelet TransfusionPostoperative HemorrhageRetrospective StudiesUnited StatesUnited States Department of Veterans AffairsConceptsFresh frozen plasmaRecombinant factor VIIaRed blood cellsVeterans Affairs hospitalTransfusion protocolFactor VIIaUnits of RBCsVeterans Affairs Connecticut Healthcare SystemUnits of FFPLarge trauma centersHospital-based blood banksETP patientsMassive transfusionTrauma centerFrozen plasmaSeparate patientsPatientsWest HavenBleeding emergenciesBlood bankBlood cellsYears' experienceHealthcare systemPlateletsHospital
2009
EDITORIAL: The problem of transfusion‐transmitted babesiosis
Young C, Krause PJ. EDITORIAL: The problem of transfusion‐transmitted babesiosis. Transfusion 2009, 49: 2548-2550. PMID: 20163687, DOI: 10.1111/j.1537-2995.2009.02494.x.Peer-Reviewed Original Research
2007
Resident and Fellow Training in Transfusion Medicine
Wu Y, Tormey C, Stack G. Resident and Fellow Training in Transfusion Medicine. Clinics In Laboratory Medicine 2007, 27: 293-342. PMID: 17556087, DOI: 10.1016/j.cll.2007.03.006.Peer-Reviewed Original Research
1999
Hold everything! Holding policies for protecting plasma supplies
Kaplan E, Satten G. Hold everything! Holding policies for protecting plasma supplies. Mathematical Biosciences 1999, 160: 159-173. PMID: 10472752, DOI: 10.1016/s0025-5564(99)00033-4.Peer-Reviewed Original ResearchHIV/AIDS in Bangladesh: An Assessment of Biomedical Risk Factors for Transmission
Gibney L, Choudhury P, Khawaja Z, Sarker M, Islam N, Vermund SH. HIV/AIDS in Bangladesh: An Assessment of Biomedical Risk Factors for Transmission. International Journal Of STD & AIDS 1999, 10: 338-346. PMID: 10361927, DOI: 10.1258/0956462991914087.Peer-Reviewed Original ResearchConceptsBiomedical risk factorsBehavioral risk factorsRisk factorsHIV/AIDSBlood supply systemHigh-risk groupFormal health care settingsCost-effective interventionHealth care settingsUnsterile injectionsHIV transmissionHIV epidemicHigh prevalenceProfessional donorsHIVPrevalenceAIDSLow levelsCertain socio-cultural factorsSocio-cultural factorsTransfusionFactorsDiseaseBlood
1991
Storage of platelet concentrates after high‐dose ultraviolet B irradiation
Snyder EL, Beardsley DS, Smith BR, Horne W, Johnson R, Wooten T, Napychank PA, Male P, Buchholz DH. Storage of platelet concentrates after high‐dose ultraviolet B irradiation. Transfusion 1991, 31: 491-496. PMID: 1853440, DOI: 10.1046/j.1537-2995.1991.31691306243.x.Peer-Reviewed Original ResearchConceptsUltraviolet B irradiationPlatelet concentratesUVB irradiationB irradiationWhite cell countGPIIb/IIIaHLA alloimmunizationPlatelet countBeta-thromboglobulinClinical trialsHours of storageUVB doseCell countBlood centersMembrane glycoprotein IbLactate dehydrogenaseSignificant decreaseControl platelet concentratesMorphology scorePlatelet deteriorationPlatelet proteinsDoseGlycoprotein IbOsmotic recoveryHoursProgressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion
Rinder H, Murphy M, Mitchell J, Stocks J, Ault K, Hillman R. Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion 1991, 31: 409-414. PMID: 1710840, DOI: 10.1046/j.1537-2995.1991.31591263195.x.Peer-Reviewed Original ResearchConceptsPercentage of plateletsPlatelet activationNormal subjectsProgressive platelet activationThrombocytopenic cancer patientsPlatelet concentrate transfusionAlpha-granule membrane protein-140Significant platelet activationConcentrate transfusionPlatelet incrementCancer patientsPlatelet recoveryThrombocytopenic patientsAutologous plateletsPosttransfusion recoveryFlow cytometryStandard blood bank conditionsGMP-140Protein 140PlateletsTransfusionPlatelet surfacePatientsSuch activationDay of collection
1990
Blood and Plasma Donations Among a Cohort of Intravenous Drug Users
Nelson K, Vlahov D, Margolick J, Bernal M, Taylor E. Blood and Plasma Donations Among a Cohort of Intravenous Drug Users. JAMA 1990, 263: 2194-2197. PMID: 1969502, DOI: 10.1001/jama.1990.03440160056037.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHIV-1 seroprevalenceIntravenous drug useDrug usersHuman immunodeficiency virus serologic statusDrug useHIV test resultsCD4 lymphocytesEntire cohortPeripheral bloodSerologic statusDonor poolIntravenous drugsHIV-1Blood donationMost subjectsPlasma donationBloodCohortDonation historySeroprevalenceDonationLymphocytesHistoryPlasma
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply